Exhaled Nitric Oxide in Children with Asthma and Short-Term PM(2.5) Exposure in Seattle by Mar, Therese F. et al.
Environmental Health Perspectives • VOLUME 113 | NUMBER 12 | December 2005 1791
Research | Children’s Health
Most studies of relationships between partic-
ulate matter (PM) air pollution and health are
based on 24-hr PM measurements. This
approach has been driven mainly by the avail-
ability of 24-hr gravimetric monitors oper-
ated by the U.S. Environmental Protection
Agency. However, there currently are several
continuous PM monitors in use for docu-
menting community exposure, and these data
allow investigators to ask questions about very
short-term (hourly) lags between health out-
comes and PM exposure. It is important to
understand the interval between exposure and
health event (lag) as fully as possible because
this may help our understanding of both the
mechanisms underlying the event and the
source of the PM.
Nitric oxide levels in airways are suggestive
of the degree of airway inflammation and
injury (Yates 2001; Bates and Silkoff 2003).
The fractional concentration of NO in exhaled
breath ( FENO) is easy to measure in exhaled
breath and is a noninvasive lung measurement
used to diagnose asthma (Jones et al. 2001;
Kharitonov and Barnes 2000; Zeidler et al.
2004). FENO is elevated in subjects with
asthma, is elevated during an asthmatic attack
(Jones et al. 2001; Silvestri et al. 2001; Yates
2001), and is reduced when subjects with
asthma are treated with anti-inflammatory
medications such as inhaled corticosteroids
(ICS) (Beck-Ripp et al. 2002). Recently, we
reported an association between 24-hr average
PM with aerodynamic diameters < 2.5 µm
(PM2.5) and FENO in children with asthma
participating in a panel study in Seattle,
Washington (Koenig et al. 2003). We
observed an approximately 4-ppb average
increase in FENO for a 10-µg/m3 increase in
PM2.5. Earlier studies also found that commu-
nity outdoor air was associated with changes in
FENO (Van Amsterdam et al. 1999, 2000).
More recently, FENO has been associated with
PM exposure in adults with cardiovascular and
respiratory disease in Steubenville, Ohio
(Adamkiewicz et al. 2004) and in adults with
respiratory disease in Seattle (Jansen et al.
2004). The Steubenville study evaluated short-
term exposures using moving-average data to
reflect cumulative exposures. They reported
associations between cumulative average PM2.5
up to 12 hr before the FENO measurement
(Adamkiewicz et al. 2004).
The objective of this study was to compare
short-term (hourly) exposures to PM with
FENO concentrations in children with asthma
and to compare these short-term results with
the earlier results. Our hypothesis was that
short-term lags would show stronger associa-
tions with FENO than would 24-hr average
lags. Deﬁning the most likely interval between
exposure and FENO response would be useful
for designing future studies.
Materials and Methods
This research was part of an intensive exposure
assessment and health effects panel study of sus-
ceptible subpopulations in Seattle from 1999
through 2002 (Koenig et al. 2003; Liu et al.
2003). Nineteen children, 6–13 years of age,
were recruited from a local asthma and allergy
clinic. All had physician-diagnosed asthma
and were prescribed asthma medications daily
or regularly. Each subject in the panel was
asked to participate for a 10-day monitoring
session in the winter of 2000–2001 and the
spring of 2001. Fourteen children partici-
pated in the FENO study during the winter
heating season, and 15 children participated
during spring. Ten participated in both sea-
sons. Approximately half of the children were
prescribed ICS therapy. The remainder was
prescribed only inhaled albuterol as needed.
Exposure data. Hourly PM2.5 data were
collected at three ﬁxed sites within the Seattle
area by the local air agency with tapered ele-
ment oscillating microbalances (TEOMs;
Rupprecht and Patashnick Co./Thermo
Electron, East Greenbush, NY). Descriptive
statistics on covariate measurements are given
in Table 1.
The average concentration of PM2.5 from
the TEOM monitors for all subjects stratiﬁed
by season and ICS use are shown in Figure 1.
Average PM2.5 concentrations vary with expo-
sure lag. PM2.5 concentrations are higher in
the winter sessions compared with spring ses-
sions, with winter peaks occurring in the late
evening/early morning hours (FENO measure-
ments were taken at or about 1600 hr Paciﬁc
standard time; see Figure 2). There is little dif-
ference in PM2.5 exposure between ICS users
and nonusers.
Exhaled NO. FENO was collected as
described in a previous report (Koenig et al.
2003). Briefly, all children participated for
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ing and health measurements. Exhaled breath
was collected in a Mylar balloon at approxi-
mately 1600 hr each day using an offline
FENO protocol. Exhaled breath was measured
with a chemiluminescent nitrogen oxide ana-
lyzer (model 200A; API, San Diego, CA).
Children were asked to refrain from eating for
1 hr before the exhaled breath collection.
Pulmonary function testing was conducted
after the exhaled breath because a deep inspi-
ration may affect FENO values (Deykin et al.
1998). Subject characteristics and FENO meas-
urements are presented in Table 2.
Statistical analysis. We assessed the associ-
ation between short-term effects of particulate
air pollution and FENO using a polynomial
distributed lag (pdl) model for PM2.5 up to
48 hr after exposure. The pdl model allows air
pollution effects at many different lags to be
estimated in the same model. The model
assumes that the air pollution effect varies
smoothly with lag, and approximates this
smooth variation by a polynomial curve. The
pdl model with 3 degrees of freedom is esti-
mated by Poisson regression using a trans-
formed set of three exposure variables that are
not highly collinear. The three estimated coef-
ﬁcients specify the polynomial curve, which in
turn gives associations at all lags. In addition
to estimating the air pollution effect over
many lags, the model can be used to estimate
the total air pollution effect by summing the
estimates at each lag (Schwartz 2000).
Pdl models are used with time-series data
where the effects of a regressor are distributed
over time. This type of model constrains the
coefﬁcients to follow a polynomial that reduces
the number of parameters and therefore
reduces the effects of collinearity in the lag
variables. Similar models have been used to
look at the effect of daily lags in air pollution
exposure and mortality (Goodman et al. 2004;
Schwartz 2000).
Equation 1 describes the model that was
used for the analysis. Each pollution variable
was modeled as a difference between the daily
PM2.5 level and the average exposure of the
subject during his or her session because we are
primarily interested in a within-subject, within-
session effect. This model also included a term
to account for the ambient concentrations of
NO that could potentially contaminate our
FENO measurements. Koenig et al. (2003) used
a similar model to look at the within-subject
effects of daily increases in PM2.5 and FENO.
Model estimates were obtained using the linear
mixed-effect equations and the generalized least
squares (GLS) estimator in Stata (version 6.0;
StataCorp, College Station, TX). As a sensitiv-
ity analysis, model estimates were also obtained
using a generalized estimating equations (GEE)
with an exchangeable working correlation
matrix and robust standard errors.
[1]
where
W is the ambient NO concentration, ids is the
PM reading for individual i on day d during
session s, is is the mean PM reading for a sub-
ject during a session, i is the mean PM reading
for a subject during all of their sessions, medi
is an indicator variable for medication use
(constant for each subject), and RH is relative
humidity.
The coefficients for each lag term were
obtained using 
Lag nγn = B1 + nB4 + n2B6 + n3B8. [2]
Results
The results of the polynomial distributed model
for the short-term effect of PM2.5 on FENO in
subjects not taking ICS are shown in Figure 3A.
Signiﬁcant increases in FENO associated with
PM2.5 can be observed in the ﬁrst 11 hr after
exposure. There is also some suggestion of an
increase in FENO between 38 and 41 hr after
exposure. The overall effect of a prolonged
exposure to PM2.5 is obtained by summing up
the estimated effects at each time lag. The sum
of all the lag coefficients (β) over 48 hr was
7.0 ppb FENO per 10-µg/m3 increase in PM2.5.
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Table 1. Summary statistics for daily averages of
temperature, relative humidity, and ambient NO.
Minimum Maximum Mean ± SD
Temperature (°F) 33 68.7 44.5 ± 6.5
Relative humidity (%) 55.3 96.5 78.6 ± 10.1
Ambient NO (ppb) 0.003 0.099 0.018 ± 0.023
Figure 1. Comparison of mean PM2.5 for all subjects stratiﬁed by season (A) or ICS medication use (B).
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Figure 2. Schematic of real-time and hourly lags
(0400 hr to 1600 hr) in PM2.5 relative to FENO collection.
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in PM2.5The short-term effects of PM2.5 on FENO
for subjects who were prescribed ICS medica-
tions are shown in Figure 3B. In general, we
found no association between FENO and
PM2.5 in subjects prescribed ICS. However, a
very small association was observed from the
18-hr lag to the 30-hr lag. This small increase
in FENO (ranging from 0.16 to 0.23 ppb per
10-µg/m3 increase in PM2.5) would not be of
clinical signiﬁcance. For ICS users, the overall
effect of PM2.5 over 48 hr is a 0.3-ppb increase
in FENO per 10-µg/m3 increase in PM2.5.
The association between FENO and PM2.5
averaged over 1 hr at various lags was also
analyzed in a single-lag, linear mixed-effects
regression model. These results are shown in
Table 3. With the single-lag model where
PM2.5 was averaged over 1 hr, we found that
7.0-ppb and 6.3-ppb increases in FENO were
associated with PM2.5 lagged 1 and 4 hr,
respectively, in subjects not taking ICS. No
association was found in subjects taking ICS.
No associations were found with a PM2.5 expo-
sure 8 hr previous in either group of children
(Table 3).
We also tested for the lag structure in
these data using a GEE model that controls
for autocorrelations in the data (Figure 4).
The distributed lag pattern was similar to that
with the linear-effects model; however, associ-
ations between FENO and PM2.5 dropped out
for the earliest hourly lags (exposures at 1 and
2 hr before breath collection).
Discussion
The objective of this study was to evaluate the
temporal relationship between prior exposure
to PM2.5 and increases in FENO in the airways
of children with asthma. Using a pdl model,
we found that FENO was associated with hourly
averaged PM2.5 exposure up to 10–12 hr
before the health measurement in subjects not
prescribed ICS. The overall effect was a 7-ppb
increase in FENO associated with a 10-µg/m3
increase in PM2.5 relative to each subject’s
mean PM2.5 exposure.
The advantage of using the pdl model
is the ability to reduce the collinearity in the
individual lags, allowing a better understanding
of the relative contribution of individual lags
and, in this case, the short-term effect of PM2.5
exposure on FENO. The similarity in results
from the analyses using the linear-effects model
with the GLS estimator and those using the
GEE model strengthens our confidence in
these results (Table 3). It is apparent from
Figure 1 that associations between PM2.5 and
FENO during the 48-hr period of analysis were
not predicted by the average PM2.5 concentra-
tion during that period, but rather by expo-
sures up to 11 hr before FENO collection.
These results are dependent on the pdl model
used; different models (e.g., ﬁrst- and second-
degree pdl) may show associations with slightly
different time patterns.
Additionally, using a single lag at speciﬁc
time periods (1, 4, and 8 hr before FENO col-
lection) for the children not prescribed ICS, we
found a 7-ppb increase in FENO for a 10-µg/m3
increase in PM2.5 exposure 1 hr earlier and a
6.3-ppb increase associated with an 10-µg/m3
increase in PM2.5 4 hr earlier. The estimate of
FENO increase is similar to that seen in the pdl
model; however, the multiple-hour curve
gives more complete information. The limita-
tion of using a single-lag model is that the
estimated PM2.5 effect at each of the lag hours
could be confounded by the effect of other lag
hours. Our single-lag model was based on
1 hr averaged PM2.5 rather than a running
average of PM2.5 for a cumulative exposure
effect. Although the pdl model is the pre-
ferred model, both the single-lag and the pdl
models resulted in similar effect estimates.
The results from our study are consistent with
those reported by Adamkiewicz et al. (2004),
who found increases in FENO significantly
associated with PM2.5 exposures up to 12 hr
previously. That study, however, used indi-
vidual hourly lag models.
The results from our analysis using the
third-degree pdl model indicate that the effect
of PM2.5 on FENO is not just immediate but
may have an effect up to 11 hr after exposure.
Because in our study FENO was measured at
approximately 1600 hr each day, this would
indicate that PM2.5 exposure from 0500 hr to
1600 hr (the time of FENO measurement) is
the relevant period of exposure. Using our
time line, this would suggest that sources that
predominate during daytime hours are most
important.
Short-term PM exposures and FENO
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Figure 3. Change in FENO per 10-µg/m3 increase in PM2.5 (A) in subjects not prescribed ICS and (B) in sub-
jects prescribed ICS therapy. TEOM readings were averaged from three central sites (Lynnwood, Lake
Forest Park, and Kent) for hourly lags from 1 to 48. Model adjusted for temperature, relative humidity, and
age. One-hour averaged PM2.5 concentrations ranged from 8.3 µg/m3 at 3-hr lag to 15.2 at 8-hr lag, sug-
gesting that short time-lag periods rather than peak values may determine this health outcome. Error bars
indicate 95% conﬁdence intervals.
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Table 3. Short-term effects of air pollution on FENO from the linear-effects model.
Metric Medication use Change in FENO 95% Conﬁdence interval p-Value
1-hr lag No meds 6.99 3.43 to 10.55 0
Meds –0.18 –3.33 to 2.97 0.911
4-hr lag No meds 6.30 2.64 to 9.97 0.001
Meds –0.77 –4.58 to 3.04 0.691
8-hr lag No meds 0.46 –1.18 to 2.11 0.58
Meds 0.40 –1.94 to 2.74 0.736
Figure 4. Change in FENO per 10-µg/m3 increase in
PM2.5 in subjects not prescribed ICS therapy. TEOM
readings averaged from three sites using GEE
model. Error bars indicate 95% conﬁdence intervals.
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Table 2. Age and FENO values stratiﬁed by age, sex, and medication use.
FENO
No. Age (mean ± SD) Minimum Maximum Mean ± SD
Sex
Female 5 11.2 ± 1.3 5 48.1 13.3 ± 6.3
Male 14 8.2 ± 1.7 5.3 79.8 16.2 ± 10.7
Medication use
ICS 9 9.7 ± 1.4 5.3 79.8 12.7 ± 7.7
No ICS 10 8.3 ± 2.4 5 72.1 18.4 ± 11.0Mar et al.
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This is one of the first studies to report
short-term temporal relationships between
PM2.5 and health outcomes in children with
asthma. In another short-term study, hourly
averages of PM were associated with respira-
tory symptoms in children with asthma
(Delfino et al. 1998). More recently, that
group, using personal monitors, reported that
associations between PM and lung function
derived from 1- or 8-hr PM2.5 averages did
not differ from associations based on 24-hr
averages (Delﬁno et al. 2004). These ﬁndings
add more information about the relationship
between PM exposure and respiratory effects
and may be useful for clinicians and patients.
This information also may be informative for
researchers in their experiment design efforts.
The relatively wide range of exposure lags
associated with increased FENO in children
with asthma that we observed suggests that
more than one mechanism may be underlying
changes in respiratory NO induced by air pol-
lution. Rapid responses are associated with
nervous system changes through nerve recep-
tors or synaptic mediators, whereas delayed
responses are sometimes attributed to up-regu-
lation of gene expression and enzyme synthe-
sis. These actions are compatible with
up-regulation of NO, which has several roles
in the lung (Deykin and Kharitonov 2003).
Coincidentally, a recent study of allergen chal-
lenges in subjects with asthma found that
FENO was initially decreased after exposure but
increased 48 hr after exposure (Ricciardolo
et al. 2003). Perhaps air pollution interactions
in the airways differ from those of proteins
such as allergens.
In conclusion, in this study we present
additional data for the use of lag structure
selection in epidemiologic studies of air pollu-
tion, an area that has received considerable
attention. Future studies using sequential
measurements of FENO will allow us to better
identify the sources of and mechanisms
underlying this health outcome.
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